Synthesis of substituted benzoxacycles via a domino ortho-alkylation/heck coupling sequence

Journal of Organic Chemistry

Volumn 71, Issue 13, 2006, Pages 4937-4942

  Martins, Andrew ^a   Marquardt, Udo ^a,b   Kasravi, Neema ^a   Alberico, Dino ^a   Lautens, Mark ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b Avir Green Hills Biotechnology AG   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLIDENE BENZOXACYCLES; BENZOXACYCLES; HECK REACTION; NORBORNENE;

ALKYLATION; BROMINE COMPOUNDS; CATALYSIS; OPTIMIZATION; PALLADIUM; REACTION KINETICS;

AROMATIC COMPOUNDS;

ACETONITRILE; ALKENE; ALKYL GROUP; BENZOXACYCLE; BENZOXAZOLE DERIVATIVE; BROMIDE; CARBONIC ACID; CESIUM; FURAN DERIVATIVE; IODIDE; NORBORNENE DERIVATIVE; PALLADIUM; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE; UNCLASSIFIED DRUG;

ALKYLATION; ARTICLE; CATALYSIS; HECK REACTION; REACTION ANALYSIS; SYNTHESIS;

ALKYLATION; BENZOXAZINES; CATALYSIS; CYCLIZATION; MOLECULAR STRUCTURE; PALLADIUM; STEREOISOMERISM;

EID: 33745478478     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo060552l     Document Type: Article

References (45)

1. Choromans are typically found as the core of the tocopherols, most importantly Vitamin E (α-tocopherol). For the subtype-specific translocation and activation of diacylglycerol kinase α by D-α-tocopherol, see: (a) Fukunaga-Takenaka, R.; Shirai, Y.; Yagi, K.; Adachi, N.; Sakai, N.; Merino, E.; Merida, I.; Saito, N. Genes Cells 2005, 10, 311-319.
2. For the inhibition of LPS-induced nitric oxide production by chromans, see: (b) Kim, B.-H.; Reddy, A. M.; Lee, K.-H.; Chung, E. Y.; Cho, S. M.; Lee, H.; Min, K. R.; Kim, Y. Biochem. Biophys. Res. Commun. 2004, 325, 223-228.
3. For the use of chromans in the treatment of cancer and inflammation, see: (c) Salvatore, B. A.; Solis, F. C. WO 2004103985, 2004.
4. For the use of chromans as antiinflammatory agents, see: (d) Salman, M.; Arora, P. K.; Ray, S.; Srimal, R. C. Indian J. Pharm. Sci. 1987, 49, 43-47.
5. For the use of 1-benzoxepines as inhibitors of farnesyl protein transferase, see: Wolin, R.; Connolly, M.; Kelly, J.; Weinstein, J.; Rosenblum, S.; Afonso, A.; James, L.; Kirschmeier, P.; Bishop, W. R. Biorg. Med. Chem. Lett. 1998, 8, 2521-2526.
6. As kappa opioid receptor agonists, see: (a) Chu, G.-H.; Gu, M.; Cassel, J. A.; Belanger, S.; Graczyk, T. M.; DeHaven, R. N.; Conway-James, N.; Koblish, M.; Little, P. J.; DeHaven-Hudkins, D. L.; Dolle, R. E. Bioorg. Med. Chem. Lett. 2005, 15, 5114-5119.
7. As estrogen receptor ligands, see: (b) Tan, Q.; Blizzard, T. A.; Morgan, J. D.; Birzin, E. T.; Chan, W.; Yang, Y. T.; Pai, L.-Y.; Hayes, E. C.; DaSilva, C. A.; Warrier, S.; Yudkovitz, J.; Wilkinson, H. A.; Sharma, N.; Fitzgerald, P. M. D.; Li, S.; Colwell, L.; Fisher, J. E.; Adamski, S.; Reszka, A. A.; Kimmel, D.; DiNinno, F.; Rohrer, S. P.; Freedman, L. P.; Schaeffer, J. M.; Hammond, M. L. Bioorg. Med. Chem. Lett. 2005, 15, 1675-1681.
8. For redox inactivation of human 15-lipoxygenase, see: (c) Cichewicz, R. H.; Kenyon, V. A.; Whitman, S.; Morales, N. M.; Arguello, J. F.; Holman, T. R.; Crews, P. J. Am. Chem. Soc. 2004, 126, 14910-14920.
9. As novel pesticides, see: (d) Yang, G.; Jiang, X.; Yang, H. Pest Manage. Sci. 2002, 58, 1063-1067.
10. As nicotine agonists, see: (e) Efange, S. M. N.; Tu, Z.; von Hohenberg, K.; Francesconi, L.; Howell, R. C.; Rampersad, M. V.; Todaro, L. J.; Papke, R. L.; Kung, M.-P. J. Med. Chem. 2001, 44, 4704-4715.
11. As IKs channel blockers, see: (f) Gerlach, U.; Brendel, J.; Lang, H.-J.; Paulus, E. F.; Weidmann, K.; Brueggemann, A.; Busch, A. E.; Suessbrich, H.; Bleich, M.; Greger, R. J. Med. Chem. 2001, 44, 3831-3837.
12. Tietze, L. F. Chem. Rev. 1996, 96, 115-136.
13. (a) Negishi, E. Handbook of Organopalladium Chemistry for Organic Synthesis; Negishi, E., Ed.; Wiley: New York, 2002.
14. (b) Tsuji, J. Palladium Reagents and Catalysts: New Perspectives for the 21st Century; Tsuji, J., Ed.; Wiley: New York, 2004.
15. (a) Catellani, M.; Frignani, F.; Rangoni, A. Angew. Chem., Int. Ed. Engl. 1997, 36, 119-122.
16. (b) Catellani, M.; Mealli, C.; Motti, E.; Paoli, P.; Perez-Carreno, E.; Pregosin, P. S. J. Am. Chem. Soc. 2002, 124, 4336-4346.
17. (c) Catellani, M. Synlett 2003, 298-313.
18. (d) Catellani, M. Top. Organomet. Chem. 2005, 14, 21-53.
19. (a) Lautens, M.; Piguel, S. Angew. Chem., Int. Ed. 2000, 39, 1045-1046.
20. (b) Lautens, M.; Paquin, J.-F.; Piguel, S.; Dahlmann, M. J. Org. Chem. 2001, 66, 8127-8134.
21. (c) Lautens, M.; Paquin, J.-F.; Piguel, S. J. Org. Chem. 2002, 67, 3972-3974.
22. (d) Pache, S.; Lautens, M. Org. Lett. 2003, 5, 4827-4830.
23. (e) Alberico, D.; Paquin, J.-F.; Lautens, M. Tetrahedron 2005, 61, 6283-6297.
24. (f) Bressy, C.; Alberico, D.; Lautens, M. J. Am. Chem. Soc. 2005, 127, 13148-13149.
25. (g) Wilhelm, T.; Lautens, M. Org. Lett. 2005, 7, 4053-4056.
26. 0" formation from Pd" salts, see: (a) Amatore, C.; Jutand, A. J. Organomet. Chem. 1999, 576, 254-278.
27. (b) Amatore, C.; Jutand, A. Acc Chem. Res. 2000, 33, 314-321.
28. For a review of the use of tri(2-furyl)phosphine in transition metal mediated reactions, see: Andersen, N. G.; Keay, B. G. Chem. Rev. 2001, 101, 997-1030.
29. Hassner, A. In Heterocyclic Compounds; Vol. 42, Part 3, Small Ring Heterocycles; Hassner, A., Ed.; John Wiley & Sons: Toronto, Canada, 1985; pp 3-152.
30. We have preliminary results for a domino ortho-alkylation/aromatic amination reaction.
31. For synthetic applications of Weinreb amides, see: (a) Sibi, M. P. Org. Prep. Proc. Int. 1993, 25, 15-42.
32. (b) Keck, G. E.; McHardy, S. F.; Murry, J. A. Tetrahedron Lett. 1993, 34, 6215-6218.
33. Mauleón, P.; Alonso, I.; Carretero, J. C. Angew. Chem., Int. Ed. 2001, 40, 1291-1293.
34. For a discussion on the effect of electron donating and withdrawing groups on the rate of oxidative addition, see: Amatore, C.; Pflüger, F. Organometallics 1990, 9, 2276-2282.
35. Ono, N. The Nitro Group in Organic Synthesis; Wiley-VCH: Chichester, UK, 2001.
36. Palladium-catalyzed cross-coupling of aryl chlorides: Selected examples in aromatic amination, see: (a) Shen, Q.; Shekhar, S.; Stambuli, J. P.; Hartwig, J. F. Angew. Chem., Int. Ed. 2005, 44, 1371-1375.
37. (b) Urgaonkar, S.; Verkade, J. G. J. Org. Chem. 2004, 69, 9135-9142.
38. In Sonogashira coupling, particularly with ortho-substituted aryl chlorides, see: (c) Gelman, D.; Buchwald, S. L. Angew. Chem., Int. Ed. 2003, 42, 5993-5996.
39. In Suzuki-Miyaura coupling, see: (d) Shen, W. Tetrahedron Lett. 1997, 38, 5575-5578.
40. (e) Anderson, K. W.; Buchwald, S. L. Angew. Chem., Int. Ed. 2005, 44, 6173-6177.
41. (f) Ozdemir, I.; Gurbuz, N.; Gok, Y.; Cetinkaya, E.; Cetinkaya, B. Synlett 2005, 2394-2396.
42. In Stille coupling, see: (g) Su, W.; Urgaonkar, S.; McLaughlin, P. A.; Verkade, J. G. J. Am. Chem. Soc. 2004, 126, 16433-16439.
43. In Heck coupling, see: (h) Littke, A. F.; Fu, G. C. J. Org. Chem. 1999, 64, 10-11.
44. In Negishi coupling, see: (i) Milne, J. E.; Buchwald, S. L. J. Am. Chem. Soc. 2004, 126, 13028-13032.
45. In Kumada coupling, see: (j) Huang, J.; Nolan, S. P. J. Am. Chem. Soc. 1999, 121, 9889-9890.